A serum microrna panel as potential biomarkers for hepatocellular carcinoma related with hepatitis b virus

PLoS ONE

Volumn 9, Issue 9, 2014, Pages e66577-

  Tan, Youwen ^a,b   Ge, Guohong ^a   Pan, Tengli ^a   Wen, Danfeng ^a   Chen, Li ^a   Yu, Xuejun ^a   Zhou, Xinbei ^a   Gan, Jianhe ^b  

^a The Third People's Hospital of Zhenjiang Affiliated Jiangsu University   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 122 5P; MICRORNA 1228 5P; MICRORNA 141 3P; MICRORNA 192 5P; MICRORNA 199A 5P; MICRORNA 206; MICRORNA 26A 5P; MICRORNA 433 3P; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; ARTICLE; BLOOD LEVEL; CANCER SCREENING; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GENE EXPRESSION PROFILING; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; BLOOD; CARCINOMA, HEPATOCELLULAR; CASE CONTROL STUDY; COMPLICATION; GENETICS; HEPATITIS B VIRUS; LIVER TUMOR; STATISTICAL MODEL; VALIDATION STUDY; VIROLOGY;

HEPATITIS B VIRUS;

BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MICRORNAS;

EID: 84907189442     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107986     Document Type: Article

References (39)

1. Flores A, Marrero JA (2014) Emerging Trends in Hepatocellular Carcinoma: Focus on Diagnosis and Therapeutics. Clin Med Insights Oncol 8: 71-76.
2. Zhao YJ, Ju Q, Li GC (2013) Tumor markers for hepatocellular carcinoma. Mol Clin Oncol 1: 593-598.
3. Giordano S, Columbano A (2013) MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? Hepatology 57: 840-847.
4. Bala S, Petrasek J, Mundkur S, Catalano D, Levin I, et al. (2012) Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 56: 1946- 1957.
5. Blanco-Calvo M, Calvo L, Figueroa A, Haz-Conde M, Anton-Aparicio L, et al. (2012) Circulating microRNAs: molecular microsensors in gastrointestinal cancer. Sensors (Basel) 12: 9349-9362.
6. Ge Y, Chen G, Sun L, Liu F (2011) [MicroRNA-29 and fibrosis diseases]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 36: 908-912.
7. He Y, Huang C, Zhang SP, Sun X, Long XR, et al. (2012) The potential of microRNAs in liver fibrosis. Cell Signal 24: 2268-2272.
8. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L (2011) Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One 6: e23937.
9. Chen YP, Jin X, Xiang Z, Chen SH, Li YM (2013) Circulating MicroRNAs as potential biomarkers for alcoholic steatohepatitis. Liver Int 33: 1257-1265.
10. Chen YJ, Zhu JM, Wu H, Fan J, Zhou J, et al. (2013) Circulating microRNAs as a Fingerprint for Liver Cirrhosis. PLoS One 8: e66577.
11. Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, et al. (2006) Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 99: 671-678.
12. Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, et al. (2008) MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47: 1955-1963.
13. Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, et al. (2010) Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBVpositive hepatocarcinoma. Cancer Res 70: 9798-9807.
14. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, et al. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658.
15. Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, et al. (2010) miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A 107: 264-269.
16. Xu J, Wu C, Che X, Wang L, Yu D, et al. (2011) Circulating microRNAs, miR- 21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 50: 136-142.
17. Zhou J, Yu L, Gao X, Hu J, Wang J, et al. (2011) Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 29: 4781-4788.
18. Zhou Q, Li M, Wang X, Li Q, Wang T, et al. (2012) Immune-related microRNAs are abundant in breast milk exosomes. Int J Biol Sci 8: 118-123.
19. Peltier HJ, Latham GJ (2008) Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14: 844-852.
20. Zhang H, Li QY, Guo ZZ, Guan Y, Du J, et al. (2012) Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B. World J Gastroenterol 18: 5188-5196.
21. Collier J, Sherman M (1998) Screening for hepatocellular carcinoma. Hepatology 27: 273-278.
22. Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S (1994) Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 19: 61-66.
23. Abdalla MA, Haj-Ahmad Y (2012) Promising Candidate Urinary MicroRNA Biomarkers for the Early Detection of Hepatocellular Carcinoma among High- Risk Hepatitis C Virus Egyptian Patients. J Cancer 3: 19-31.
24. Petrelli A, Perra A, Cora D, Sulas P, Menegon S, et al. (2014) MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). Hepatology 59: 228-241.
25. Li J, Wang Y, Yu W, Chen J, Luo J (2011) Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance. Biochem Biophys Res Commun 406: 70-73.
26. Tomimaru Y, Eguchi H, Nagano H, Wada H, Kobayashi S, et al. (2012) Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J Hepatol 56: 167-175.
27. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, et al. (2006) Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25: 2537-2545.
28. Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, et al. (2008) Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 14: 419-427.
29. Hou J, Lin L, Zhou W, Wang Z, Ding G, et al. (2011) Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b- 3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19: 232-243.
30. Morita K, Taketomi A, Shirabe K, Umeda K, Kayashima H, et al. (2011) Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C. Liver Int 31: 474-484.
31. Chang J, Nicolas E, Marks D, Sander C, Lerro A, et al. (2004) miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol 1: 106-113.
32. Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, et al. (2008) Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 68: 5049-5058.
33. Hsu SH, Wang B, Kota J, Yu J, Costinean S, et al. (2012) Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest 122: 2871-2883.
34. Tsai WC, Hsu SD, Hsu CS, Lai TC, Chen SJ, et al. (2012) MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest 122: 2884-2897.
35. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, et al. (2009) Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137: 1005-1017.
36. Ji J, Shi J, Budhu A, Yu Z, Forgues M, et al. (2009) MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 361: 1437-1447.
37. Qu KZ, Zhang K, Li H, Afdhal NH, Albitar M (2011) Circulating microRNAs as biomarkers for hepatocellular carcinoma. J Clin Gastroenterol 45: 355-360.
38. Debruyne EN, Delanghe JR (2008) Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. Clin Chim Acta 395: 19-26.
39. Song P, Tobe RG, Inagaki Y, Kokudo N, Hasegawa K, et al. (2012) The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011. Liver Int 32: 1053-1063.